Diarrhea in liver transplant recipients: Etiology and management

被引:100
作者
Ginsburg, PM [1 ]
Thuluvath, PJ [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD USA
关键词
D O I
10.1002/lt.20500
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Diarrhea is common after liver transplantation (LT). The true incidence of diarrhea in liver transplant recipients is unknown but possibly ranges from 10% to 43% based on a few published studies in other solid organ and bone marrow transplantation. Infectious etiologies, including cytomegalovirus (CMV), Clostridium difficile, and occasional atypical intestinal infections, are the most common causes. Diarrhea is also a frequent side effect of immunosuppressive medications. To variable extents, mycophenolate mofetil (MMF), cyclosporine A (CSA), tacrolimus, and sirolimus are all known to be associated with diarrhea. Rarely, graft-versus-host disease (GVHD), lymphoproliferative disorder, de novo inflammatory bowel disease (IBD), or colon cancer may present as diarrhea. Flare-up of preexisting IBD is also not uncommon after LT. However, the cause of acute diarrhea remains unidentified in 1 of 3 patients. This review summarizes the literature and provides recommendations on the management of acute diarrhea after LT. Although our focus is on LT, the etiology and management recommendations apply to most transplant recipients.
引用
收藏
页码:881 / 890
页数:10
相关论文
共 93 条
[1]   CYTOMEGALO-VIRUS INFECTION OF THE UPPER GASTROINTESTINAL-TRACT BEFORE AND AFTER LIVER-TRANSPLANTATION [J].
ALEXANDER, JA ;
CUELLAR, RE ;
FADDEN, RJ ;
GENOVESE, JJ ;
GAVALER, JS ;
VANTHIEL, DH .
TRANSPLANTATION, 1988, 46 (03) :378-382
[2]   Diarrhoea following renal transplantation [J].
Altiparmak, MR ;
Trablus, S ;
Pamuk, ÖN ;
Apaydin, S ;
Sariyar, M ;
Öztürk, R ;
Ataman, R ;
Serdengeçti, K ;
Erek, E .
CLINICAL TRANSPLANTATION, 2002, 16 (03) :212-216
[3]   Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy [J].
Atassi, T ;
Thuluvath, PJ .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (01) :72-73
[4]  
Barkholt L, 1999, Transpl Infect Dis, V1, P89, DOI 10.1034/j.1399-3062.1999.010202.x
[5]   Clinical course and management of inflammatory bowel disease after liver transplantation [J].
Befeler, AS ;
Lissoos, TW ;
Schiano, TD ;
Conjeevaram, H ;
Dasgupta, KA ;
Millis, JM ;
Newell, KA ;
Thistlethwaite, JR ;
Baker, AL .
TRANSPLANTATION, 1998, 65 (03) :393-396
[6]   INCREASED RISK OF EARLY COLORECTAL NEOPLASMS AFTER HEPATIC TRANSPLANT IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE [J].
BLEDAY, R ;
LEE, E ;
JESSURUN, J ;
HEINE, J ;
WONG, WD .
DISEASES OF THE COLON & RECTUM, 1993, 36 (10) :908-912
[7]   Risk and natural history of colonic neoplasia in patients with primacy sclerosing cholangitis and ulcerative colitis [J].
Brentnall, TA ;
Haggitt, RC ;
Rabinovitch, PS ;
Kimmey, MB ;
Bronner, MP ;
Levine, DS ;
Kowdley, KV ;
Stevens, AC ;
Crispin, DA ;
Emond, M ;
Rubin, CE .
GASTROENTEROLOGY, 1996, 110 (02) :331-338
[8]   Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C [J].
Burak, KW ;
Kremers, WK ;
Batts, KP ;
Wiesner, RH ;
Rosen, CB ;
Razonable, RR ;
Paya, CV ;
Charlton, MR .
LIVER TRANSPLANTATION, 2002, 8 (04) :362-369
[9]  
BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110
[10]   Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction [J].
Cantarovich, M ;
Tzimas, GN ;
Barkun, J ;
Deschenes, M ;
Alpert, E ;
Tchervenkov, J .
TRANSPLANTATION, 2003, 76 (01) :98-102